Premium
Comparative Effects of Acetylated and Unmodified High‐amylose Maize Starch in Rats
Author(s) -
Morita Tatsuya,
Kasaoka Seiichi,
Kiriyama Shuhachi,
Brown Ian L.,
Topping David L.
Publication year - 2005
Publication title -
starch ‐ stärke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.62
H-Index - 82
eISSN - 1521-379X
pISSN - 0038-9056
DOI - 10.1002/star.200400373
Subject(s) - starch , food science , chemistry , maize starch , fermentation , potato starch , amylose , polysaccharide , resistant starch , biochemistry
Acetylated, propionylated or butyrylated starches raise the large bowel pools of these short chain fatty acids (SCFA) in rats but their resistant starch (RS) content in vivo is unknown. This content was determined for acetylated starch (Starch A, DS = 0.18) in colectomised rats and compared to a standard maize (control) or high‐amylose (HAMS) maize starch. Digestibilities were 99.8% (control), 47.5% (Starch A) and 58% (HAMS). The effects of Starch A and HAMS were compared also in intact rats, that were fed a fibre‐free diet in which either 200 g/kg of HAMS or 100, 200 or 300 g of Starch A/kg was substituted for the standard maize starch. Caecal SCFA pools were larger in rats fed either RS with the greatest increase being in acetate in rats fed Starch A. Other acids (succinate and formate) appeared with increasing incorporation of RS. However, when the experiment was performed with a commercial diet, feeding Starch A or HAMS did not lead to any great increase in these other acids but SCFA pools expanded. The greatest increase in acetate was in rats fed Starch A. This suggests that other factors were necessary for optimal RS fermentation but not for release of acetate from Starch A. Comparison of the effects of Starch A and HAMS on SCFA suggests that the former was at least 100% more effective than HAMS at equivalent dietary intakes, despite similarities in RS content. Incubation of Starch A with caecal bacterial enzymes confirmed that release of acetate was relatively slow, indicating a capacity of this modified starch for sustained SCFA delivery in vivo.